Svetlana Lagercrantz-Bajalica

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.

Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.

Journal: JAMA network open
Published: April 03, 2026

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 14, 2025

TP53 p.R181H is enriched in the Swedish cohort (SWEP53) and associated with a distinct breast and prostate phenotype.

TP53 p.R181H is enriched in the Swedish cohort (SWEP53) and associated with a distinct breast and prostate phenotype.

Journal: Scientific reports
Published: July 03, 2025

Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.

Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.

Journal: European journal of human genetics : EJHG
Published: June 23, 2025

The genomic medicine center Karolinska 10-year report on genome sequencing for rare diseases and a strategy for stepwise clinical implementation.

The genomic medicine center Karolinska 10-year report on genome sequencing for rare diseases and a strategy for stepwise clinical implementation.

Journal: Genome medicine
Published: May 31, 2025

Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival.

Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival.

Journal: ESMO open
Published: April 22, 2024

Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Journal: European journal of human genetics : EJHG
Published: February 28, 2024

Investigation of Genetic Alterations Associated With Interval Breast Cancer.

Investigation of Genetic Alterations Associated With Interval Breast Cancer.

Journal: JAMA oncology
Published: January 25, 2024

Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives.

Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives.

Journal: European journal of human genetics : EJHG
Published: June 29, 2023

Prediction of breast cancer risk for sisters of women attending screening.

Prediction of breast cancer risk for sisters of women attending screening.

Journal: Journal of the National Cancer Institute
Published: January 09, 2023

Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.

Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.

Journal: Cancer
Published: October 13, 2022

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

Journal: The Lancet. Oncology
Published: July 17, 2022
Showing 1-12 of 25

Last Updated: 09/26/2026